BRWM
ALXN

B. Riley Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

B. Riley Wealth Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-25
Closed -$4K – 846
2015
Q2 		$4K Sell
25
-100
-80% -$17.3K ﹤0.01% 900
2015
Q1 		$21K Hold
125
– – 0.02% 605
2014
Q4 		$23K Buy
+125
New +$23.2K 0.02% 559
2014
Q3 		– Sell
-1,890
Closed -$295K – 1184
2014
Q2 		$295K Sell
1,890
-4,823
-72% -$762K 0.19% 146
2014
Q1 		$1.02M Buy
+6,713
New +$1.07M 0.75% 19

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

B. Riley Wealth Management's ALXN Position: Q3 2015 in Review

B. Riley Wealth Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2015, closing a stake of 25 shares — an estimated $4K sold.

B. Riley Wealth Management first reported a position in ALXN in Q1 2014 and held it in 5 quarters. The position peaked at $1.02M in Q1 2014. 515 funds tracked by Wall St. Rank hold ALXN as of Q3 2015.

  • B. Riley Wealth Management reported no remaining Alexion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • B. Riley Wealth Management sold 25 Alexion Pharmaceuticals shares in Q3 2015, an estimated $4K.
  • B. Riley Wealth Management first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 5 quarters.
  • B. Riley Wealth Management's Alexion Pharmaceuticals position peaked at $1.02M in Q1 2014.
  • 515 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2015.

Based on B. Riley Wealth Management's 13F filing for Q3 2015, filed 13 Oct 2015.